Jan 5, 2026 07:00AM
Oct 22, 2025 04:51PM
Oct 22, 2025 04:50PM
Oct 20, 2025 09:05AM
Oct 20, 2025 09:05AM
Mar 12, 2025 07:00AM
Feb 27, 2025 07:00AM RedHill Presents Business Update at the Sachs' European Life Sciences CEO Forum
Feb 25, 2025 07:04AM
Feb 25, 2025 07:00AM
Dec 26, 2023 12:00PM
Dec 21, 2023 12:30PM
Jun 8, 2023 11:59AM
May 2, 2023 01:00AM
Apr 28, 2023 01:00AM Hyloris releases Annual Report 2022, including ESG objectives
Apr 18, 2023 01:00AM
Mar 15, 2023 02:03PM
Jan 24, 2023 01:00AM
Jan 20, 2023 01:00AM
Nov 22, 2022 12:00PM
Oct 12, 2022 10:00AM
Sep 6, 2022 03:00AM Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m to Progress its Novel Plecoid™ Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU
Sep 1, 2022 01:00AM
Jul 20, 2022 01:00AM
Jul 1, 2022 02:00PM
Jul 1, 2022 03:55AM
Mar 16, 2022 02:00AM
Dec 17, 2021 01:00AM
Nov 15, 2021 01:00AM Hyloris Announces Earlier than Expected PDUFA Date for Maxigesic® IV
Nov 10, 2021 01:00AM
Nov 10, 2021 01:00AM
Nov 2, 2021 02:00AM
Nov 1, 2021 02:00AM
Oct 19, 2021 01:00AM
Oct 13, 2021 01:00AM
Oct 8, 2021 01:00AM Hyloris Expands Cardiovascular Pipeline with Breakthrough Extended-Release Milrinone Capsule in Late-Stage Heart Failure
Sep 23, 2021 01:00AM
Sep 21, 2021 01:00AM
Aug 4, 2021 01:00AM
Jul 27, 2021 01:00AM
Jul 8, 2021 01:00AM
Jun 24, 2021 01:00AM
May 6, 2021 01:00AM Hyloris annonce l'extension de l'empreinte de Maxigesic® IV en Amérique du Sud
Apr 28, 2021 01:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All